The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwCLL 2023 | Anti-tumor immunity in the lymphoid microenvironment
In this video, Martina Seiffert, PhD, German Cancer Research Center, Heidelberg, Germany, briefly comments on the need to study the lymphatic microenvironment of patients with chronic lymphocytic leukemia (CLL) in order to identify the cellular changes which are indicative of anti-tumor immunity. This interview was recorded at the biennial International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2023 meeting, held in Boston, MA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
